[Diagnosis and treatment of interstitial cystitis].

Abstract

Interstitial Cystitis, first described in 1887 as an inflammatory disease of the bladder wall, is now regarded as a very common disease with an estimated number of unreported cases. Reasons for underdiagnosis is the widespread use of strict exclusion criteria. The disease can already be suspected by a careful medical history and physical examination in an early stage and then be treated with promising multimodal therapeutic approaches. In addition to a symptomatic oral therapy, local instillations with constituents of the protective glycosaminoglycan-layer are the most common therapeutic approach, because its defective integrity plays a key role in the pathogenesis of interstitial cystitis.

• Authors: D Meyer, J Gregorin, H-P Schmid
• Journal: Praxis (Praxis (Bern 1994)) Vol. 100 Issue 4 Pg. 221-7 (Feb 16 2011) ISSN: 1661-8157 [Print] Switzerland
• Vernacular Title: Diagnostik und Therapie der interstitiellen Zystitis.
• PMID: 21328236 (Publication Type: Comparative Study, English Abstract, Journal Article, Review)

Chemical References

• Analgesics
• Anticoagulants
• Antidepressive Agents, Tricyclic
• Cholinergic Antagonists
• Pentosan Sulfuric Polyester

Topics

• Administration, Oral
• Adult
• Aged
• Aged, 80 and over
• Analgesics (administration & dosage, therapeutic use)
• Anticoagulants (administration & dosage, therapeutic use)
• Antidepressive Agents, Tricyclic (administration & dosage, therapeutic use)
• Child, Preschool
• Cholinergic Antagonists (administration & dosage, therapeutic use)
• Combined Modality Therapy
• Cystitis, Interstitial (diagnosis, drug therapy, epidemiology, etiology, pathology, therapy)
• Cystoscopy
• Drug Therapy, Combination
• Female
• Humans
• Male
• Medical History Taking
• Middle Aged
• Pentosan Sulfuric Polyester (administration & dosage, therapeutic use)
• Randomized Controlled Trials as Topic
• Risk Factors
• Sex Factors
• Socioeconomic Factors
• Urinary Bladder (pathology)